On the recordMay 13, 2023
I thought at least the FDA label on mifepristone should change based on the alarming report.
Source
vox.comI thought at least the FDA label on mifepristone should change based on the alarming report.
Kennedy suggests the FDA label for mifepristone needs revision due to safety concerns.
Share
More from Robert F. Kennedy, Jr.
Most organ procurement organizations carry out this work with professionalism, compassion, and deep respect for both donors and recipients.
The performance was a replay of the Democrats' COVID playbook: fearmongering, misinformation, finger-pointing, and the weaponization of infectious disease fears for political gain.
We will support patient autonomy, require informed consent and shared decision-making, and shift the standard of care toward prevention, transparency and a more holistic approach to mental health.